LIPOCINE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.7 USD | -0.21% |
|
+3.30% | +68.46% |
| May. 01 | Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 | CI |
| Apr. 12 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 6.510 | 6.510 | 5.810 |
| Spread/Res. | -27.80% | -27.80% | -19.10% |
| Spread/Supp. | +16.34% | +16.34% | +30.19% |
| Support | 4.040 | 4.040 | 3.610 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LPCN Stock
- Charts Lipocine Inc.
